Takashi Yokokawa

7PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - carbohydrates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 01, 2026
Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

|Nov 05, 2025
Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC.

Kazuo Kobayashi, Takeru Wakatsuki, Erika Sugiyama

|Nov 16, 2024
A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II).

Kenichi Suzuki, Takashi Yokokawa, Takashi Kawaguchi

|Apr 29, 2024
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).

Masahiro Hatori, Daiki Tsuji, Kenichi Suzuki

|Sep 07, 2023
Influence of menopause on chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study.

Takashi Yokokawa, Kenichi Suzuki, Daiki Tsuji

|Nov 08, 2022
Fast and Ultrasensitive Glycoform Analysis by Supercritical Fluid Chromatography-Tandem Mass Spectrometry.

Yoshimi Haga, Masaki Yamada, Risa Fujii

Pageof 2

Frequent Collaborators

4 joint publications

Kazuo Kobayashi

4 joint publications

Kazuyoshi Kawakami

4 joint publications

Daiki Tsuji

3 joint publications

Takeshi Aoyama